Showing results (21-30 of 112) with videos related to
Sort By:
Pageof 12
Bone Marrow Transplantation|March 7, 2003
Graft-versus-leukaemia effect in children: chronic GVHD has a significant impact on relapse and survivalA Gustafsson Jernberg, M Remberger, O Ringdén, et al.Gut|June 20, 2001
Tumour necrosis factor alpha impairs function of liver derived T lymphocytes and natural killer cells in patients with primary sclerosing cholangitisX Bo, U Broome, M Remberger, et al.Bone Marrow Transplantation|September 1, 2009
Sequential Organ Failure Assessment predicts the outcome of SCT recipients admitted to intensive care unitK Gilli, M Remberger, H Hjelmqvist, et al.Obstetrics and Gynecology|August 1, 1995
Cytokines in fetal blood and amniotic fluid in Rh-immunized pregnanciesM Westgren, S Ek, M Remberger, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 31, 2013
Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantationsO Blennow, P Ljungman, E Sparrelid, et al.Applied and Environmental Microbiology|February 1, 1988
Methylation of halogenated phenols and thiophenols by cell extracts of gram-positive and gram-negative bacteriaA H Neilson, C Lindgren, P A Hynning, et al.Bone Marrow Transplantation|July 31, 2007
Cyclosporine A (CsA) 2-h concentrations vary between patients without correlation to graft-versus-host disease after allogeneic haematopoietic stem cell transplantationL Barkholt, M Remberger, H Bodegård, et al.Applied and Environmental Microbiology|October 1, 1987
Transformations of chloroguaiacols, chloroveratroles, and chlorocatechols by stable consortia of anaerobic bacteriaA H Neilson, A S Allard, C Lindgren, et al.Scandinavian Journal of Immunology|November 1, 1993
Immune modulatory effects of immunoglobulins on cell-mediated immune responses in vitroS Klaesson, O Ringdén, L Markling, et al.Bone Marrow Transplantation|September 22, 1999
Low-dose cyclosporine of short duration increases the risk of mild and moderate GVHD and reduces the risk of relapse in HLA-identical sibling marrow transplant recipients with leukaemiaS Carlens, J Aschan, M Remberger, et al.Pageof 12